trending Market Intelligence /marketintelligence/en/news-insights/trending/oqKkypEhTkCKkx5Arco6kA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Cardax plans 200-for-1 reverse stock split

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Cardax plans 200-for-1 reverse stock split

Cardax Inc. said it will effect a 200-for-1 reverse split of its issued and outstanding common stock.

The Honolulu-based biopharmaceutical company said the reverse stock split will be effective at 12:01 a.m. ET on Jan. 15.

The company's common stock will trade on the OTCQB on a split-adjusted basis under its current CDXI ticker symbol.

No fractional shares will be issued under the stock split. Fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share.

Cardax develops dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress.